Liver X receptors as therapeutic targets for managing cholesterol

Implications for inflammatory conditions

Yuan Zhang, Jessica F. Chan, Carolyn L. Cummins

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Atherosclerosis is a disease characterized by excess cholesterol and inflammation in the blood vessels. The liver X receptors (α and β) are members of the nuclear hormone receptor family that are activated by endogenous cholesterol metabolites. These receptors are widely expressed with a tissue distribution that includes the liver, intestine and macrophage. Upon activation, these receptors have been shown to increase reverse cholesterol transport from the macrophage back to the liver to aid in the removal of excess cholesterol. More recently, they have also been shown to inhibit the inflammatory response in macrophages. These functions are accomplished through direct regulation of gene transcription. Herein, we will describe the key benefits and potential risks of targeting the liver X receptors for the treatment of atherosclerosis.

Original languageEnglish (US)
Pages (from-to)29-40
Number of pages12
JournalFuture Lipidology
Volume4
Issue number1
DOIs
StatePublished - 2009

Fingerprint

Liver
Macrophages
Cholesterol
Atherosclerosis
Blood vessels
Tissue Distribution
Transcription
Therapeutics
Cytoplasmic and Nuclear Receptors
Metabolites
Intestines
Blood Vessels
Genes
Chemical activation
Tissue
Inflammation
Liver X Receptors

Keywords

  • ABCA1
  • Adrenal gland
  • Atherosderosis
  • Brain
  • Cholesterol
  • Inflammation
  • Liver
  • Lung
  • LXR
  • Reverse cholesterol transport
  • SREBP-1c

ASJC Scopus subject areas

  • Biochemistry

Cite this

Liver X receptors as therapeutic targets for managing cholesterol : Implications for inflammatory conditions. / Zhang, Yuan; Chan, Jessica F.; Cummins, Carolyn L.

In: Future Lipidology, Vol. 4, No. 1, 2009, p. 29-40.

Research output: Contribution to journalArticle

Zhang, Yuan ; Chan, Jessica F. ; Cummins, Carolyn L. / Liver X receptors as therapeutic targets for managing cholesterol : Implications for inflammatory conditions. In: Future Lipidology. 2009 ; Vol. 4, No. 1. pp. 29-40.
@article{4ea8aa6c630c416894f39b3fe12ec586,
title = "Liver X receptors as therapeutic targets for managing cholesterol: Implications for inflammatory conditions",
abstract = "Atherosclerosis is a disease characterized by excess cholesterol and inflammation in the blood vessels. The liver X receptors (α and β) are members of the nuclear hormone receptor family that are activated by endogenous cholesterol metabolites. These receptors are widely expressed with a tissue distribution that includes the liver, intestine and macrophage. Upon activation, these receptors have been shown to increase reverse cholesterol transport from the macrophage back to the liver to aid in the removal of excess cholesterol. More recently, they have also been shown to inhibit the inflammatory response in macrophages. These functions are accomplished through direct regulation of gene transcription. Herein, we will describe the key benefits and potential risks of targeting the liver X receptors for the treatment of atherosclerosis.",
keywords = "ABCA1, Adrenal gland, Atherosderosis, Brain, Cholesterol, Inflammation, Liver, Lung, LXR, Reverse cholesterol transport, SREBP-1c",
author = "Yuan Zhang and Chan, {Jessica F.} and Cummins, {Carolyn L.}",
year = "2009",
doi = "10.2217/17584299.4.1.29",
language = "English (US)",
volume = "4",
pages = "29--40",
journal = "Clinical Lipidology",
issn = "1758-4299",
publisher = "Future Medicine Ltd.",
number = "1",

}

TY - JOUR

T1 - Liver X receptors as therapeutic targets for managing cholesterol

T2 - Implications for inflammatory conditions

AU - Zhang, Yuan

AU - Chan, Jessica F.

AU - Cummins, Carolyn L.

PY - 2009

Y1 - 2009

N2 - Atherosclerosis is a disease characterized by excess cholesterol and inflammation in the blood vessels. The liver X receptors (α and β) are members of the nuclear hormone receptor family that are activated by endogenous cholesterol metabolites. These receptors are widely expressed with a tissue distribution that includes the liver, intestine and macrophage. Upon activation, these receptors have been shown to increase reverse cholesterol transport from the macrophage back to the liver to aid in the removal of excess cholesterol. More recently, they have also been shown to inhibit the inflammatory response in macrophages. These functions are accomplished through direct regulation of gene transcription. Herein, we will describe the key benefits and potential risks of targeting the liver X receptors for the treatment of atherosclerosis.

AB - Atherosclerosis is a disease characterized by excess cholesterol and inflammation in the blood vessels. The liver X receptors (α and β) are members of the nuclear hormone receptor family that are activated by endogenous cholesterol metabolites. These receptors are widely expressed with a tissue distribution that includes the liver, intestine and macrophage. Upon activation, these receptors have been shown to increase reverse cholesterol transport from the macrophage back to the liver to aid in the removal of excess cholesterol. More recently, they have also been shown to inhibit the inflammatory response in macrophages. These functions are accomplished through direct regulation of gene transcription. Herein, we will describe the key benefits and potential risks of targeting the liver X receptors for the treatment of atherosclerosis.

KW - ABCA1

KW - Adrenal gland

KW - Atherosderosis

KW - Brain

KW - Cholesterol

KW - Inflammation

KW - Liver

KW - Lung

KW - LXR

KW - Reverse cholesterol transport

KW - SREBP-1c

UR - http://www.scopus.com/inward/record.url?scp=67149111712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67149111712&partnerID=8YFLogxK

U2 - 10.2217/17584299.4.1.29

DO - 10.2217/17584299.4.1.29

M3 - Article

VL - 4

SP - 29

EP - 40

JO - Clinical Lipidology

JF - Clinical Lipidology

SN - 1758-4299

IS - 1

ER -